Garland Surgical Targets Hip Arthroplasty Market Disruption with Successful Close of €3.5M Seed Round and Preparation for Series A Financing Launch (opens in new tab)

Building on its recent €3.5M seed round, Garland Surgical launches preparations for a larger Series A financing to unlock commercialisation of its patented TriActiv Hip™ system. The post Garland Surgical Targets Hip Arthroplasty Market Disruption with Successful Close of €3.5M Seed Round and Preparation for Series A Financing Launch appeared first on Orthopedics This Week.